Reviewing Envoy Medical (NASDAQ:COCH) & Demant A/S (OTCMKTS:WILYY)

Demant A/S (OTCMKTS:WILYY) and Envoy Medical (NASDAQ:COCH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

Profitability

This table compares Demant A/S and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Demant A/S	N/A	N/A	N/A
Envoy Medical	N/A	N/A	-112.11%

Analyst Recommendations

This is a breakdown of current ratings and target prices for Demant A/S and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Demant A/S	0	0	2	0	3.00
Envoy Medical	0	0	3	0	3.00

Envoy Medical has a consensus target price of $7.25, indicating a potential upside of 234.10%. Given Envoy Medical’s higher possible upside, analysts plainly believe Envoy Medical is more favorable than Demant A/S.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. 0.7% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Demant A/S and Envoy Medical’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Demant A/S	$3.26 billion	2.39	$260.63 million	N/A	N/A
Envoy Medical	$297,000.00	143.21	-$29.91 million	N/A	N/A

Demant A/S has higher revenue and earnings than Envoy Medical.

Risk and Volatility

Demant A/S has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.29, meaning that its stock price is 129% more volatile than the S&P 500.

Summary

Envoy Medical beats Demant A/S on 6 of the 9 factors compared between the two stocks.

About Demant A/S

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.